2001
DOI: 10.1067/mge.2001.115007
|View full text |Cite
|
Sign up to set email alerts
|

Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
88
0
5

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 151 publications
(96 citation statements)
references
References 24 publications
3
88
0
5
Order By: Relevance
“…According to published reports, hypoenhancing masses were regarded as a sign of malignancy in CEH-EUS. The first feasibility study reported good values of sensitivity, specificity and accuracy for the differential diagnosis between adenocarcinoma and focal chronic pancreatitis [53] . This was further confirmed in two other studies by Sakamoto et al [54] and Dietrich et al [55] in which adenocarcinomas showed hypoenhancement compared with neuroendocrine tumors and pseudotumoral (mass-forming) pancreatitis, which cer staging and assessing resectability is CT because its low cost and high availability [72] and MRI for preoperative assessment of pancreatic cancer, with an accuracy of 86% vs 71% even with comparable sensitivity of MRI for detecting pancreatic cancer (88%-96%) [73] .…”
Section: Contrast-enhanced Eus (Ceh-eus) Is Performedmentioning
confidence: 99%
“…According to published reports, hypoenhancing masses were regarded as a sign of malignancy in CEH-EUS. The first feasibility study reported good values of sensitivity, specificity and accuracy for the differential diagnosis between adenocarcinoma and focal chronic pancreatitis [53] . This was further confirmed in two other studies by Sakamoto et al [54] and Dietrich et al [55] in which adenocarcinomas showed hypoenhancement compared with neuroendocrine tumors and pseudotumoral (mass-forming) pancreatitis, which cer staging and assessing resectability is CT because its low cost and high availability [72] and MRI for preoperative assessment of pancreatic cancer, with an accuracy of 86% vs 71% even with comparable sensitivity of MRI for detecting pancreatic cancer (88%-96%) [73] .…”
Section: Contrast-enhanced Eus (Ceh-eus) Is Performedmentioning
confidence: 99%
“…Two months later, we performed an Oc− treoscan and serum tests of vasoactive intestinal peptide (VIP) and chromogra− nin A (CgA), which were normal. EUS with contrast enhanced detected areas of fibrosis [3]. At present, after a follow−up period of 18 months, the patient is asymptomatic, without recurrent dis− ease; abdominal nuclear magnetic reso− nance is negative.…”
mentioning
confidence: 96%
“…In addition, EUS demonstrated a limited potential for the prediction of histologic types of lesions [84] . Whether, as concluded from a small study on 23 patients, echo-enhanced power-Doppler EUS can reliably differentiate pancreatic neoplasms and focal pancreatitis [85] remains to be seen when applied to larger patient groups.…”
Section: Role Of Eusmentioning
confidence: 99%